Publications 2024

Bramness JG, Lien L, Moe JS, Toft H, Pandey S, Lid TG, Strømmen M, Andersen JR, Bolstad I (2024)
Bariatric surgery patients in AUD treatment in Norway-an exploratory cross-sectional study
Alcohol Alcohol, 59 (2)
DOI 10.1093/alcalc/agae007, PubMed 38369663

Chalabianloo F, Fadnes LT, Johansson KA, Høiseth G, Vold JH, Kringen MK, Spigset O, Bramness JG (2024)
Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications
Basic Clin Pharmacol Toxicol, 134 (3), 333-344
DOI 10.1111/bcpt.13975, PubMed 38124280

Nygaard-Odeh K, Soloy-Nilsen H, Kristiansen MG, Brekke OL, Mollnes TE, Berk M, Bramness JG, Oiesvold T (2024)
Cytokines in hepatitis C-infected patients with or without opioid maintenance therapy
Acta Neuropsychiatr, 1-7 (in press)
DOI 10.1017/neu.2023.56, PubMed 38173235

Rodríguez-Cano R, Lotre K, von Soest T, Rognli EB, Bramness JG (2024)
Loneliness in adolescence and prescription of psychotropic drugs in adulthood: 23-year longitudinal population-based and registry study
BJPsych Open, 10 (2), e61
DOI 10.1192/bjo.2024.22, PubMed 38465662

Rognli EB, Høye A, Bramness JG (2024)
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al
Am J Psychiatry, 181 (2), 168-169
DOI 10.1176/appi.ajp.20230522, PubMed 38298080

Publications 2023

Berger E, Bolstad I, Lien L, Bramness JG (2023)
The Association Between Regular Physical Activity and Depressive Symptoms Among Patients in Treatment of Alcohol and Substance Use Disorders
Subst Abuse, 17, 11782218231175813
DOI 10.1177/11782218231175813, PubMed 37223087

Bolstad I, Lien L, Moe JS, Pandey S, Toft H, Bramness JG (2023)
Inflammatory cytokines in alcohol use disorder patients are lower in smokers and users of smokeless tobacco
Alcohol Clin Exp Res (Hoboken), 47 (7), 1352-1363
DOI 10.1111/acer.15103, PubMed 37208927

Bramness JG, Edland-Gryt M (2023)
[Not Available]
Tidsskr Nor Laegeforen, 143 (1)
DOI 10.4045/tidsskr.23.0680, PubMed 38258712

Bramness JG, Heiberg IH, Høye A, Rossow I (2023)
Mortality and alcohol-related morbidity in patients with delirium tremens, alcohol withdrawal state or alcohol dependence in Norway: A register-based prospective cohort study
Addiction, 118 (12), 2352-2359
DOI 10.1111/add.16297, PubMed 37465900

Bramness JG, Leonhardt M, Dom G, Batalla A, Flórez Menéndez G, Mann K, Wurst FM, Wojnar M, Drummond C, Scafato E, Gual A, Ribeiro CM, Cottencin O, Frischknecht U, Rolland B (2023)
Education and Training in Addiction Medicine and Psychology across Europe: A EUFAS Survey
Eur Addict Res, 1-11 (in press)
DOI 10.1159/000531502, PubMed 37557089

Bramness JG, Pandey S, Moe JS, Toft H, Lien L, Walby FA, Myhre MØ, Bolstad I (2023)
Levels of IL-6 are Associated with Lifetime Attempted Suicide in Alcohol Use Disorder Patients
Neuropsychiatr Dis Treat, 19, 2141-2148
DOI 10.2147/NDT.S413101, PubMed 37849526

Bramness JG, Skulberg KR, Skulberg A, Moe JS, Mørland J (2023)
The Self-Rated Effects of Alcohol Are Related to Presystemic Metabolism of Alcohol
Alcohol Alcohol, 58 (2), 203-208
DOI 10.1093/alcalc/agad002, PubMed 36715301

Bramness JG, Syse A, Rognli EB (2023)
[Substance-induced psychosis – a problematic diagnosis]
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.22.0762, PubMed 36811432

Kerr-Little A, Bramness JG, Newberry RC, Biong S (2023)
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study
Addict Sci Clin Pract, 18 (1), 57
DOI 10.1186/s13722-023-00411-z, PubMed 37759274

Leonhardt M, Bramness JG, Lien L (2023)
Incidence of SARS-CoV-2 and all-cause mortality in persons with co-occurring substance use disorder and mental illness during the pandemic: a Norwegian cohort study
Soc Psychiatry Psychiatr Epidemiol (in press)
DOI 10.1007/s00127-023-02599-6, PubMed 38015236

Myhre MØ, Walby FA, Bramness JG, Mehlum L (2023)
The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders: a National registry study
Addict Sci Clin Pract, 18 (1), 59
DOI 10.1186/s13722-023-00415-9, PubMed 37821976

Nystad W, Hjellvik V, Larsen IK, Robsahm TE, Sund ER, Krokstad S, Hopstock LA, Grimsgaard S, Langhammer A, Bramness JG, Wisløff T, Lergenmuller S, Dalene KE, Meyer HE, Holvik K, Helgeland J, Karlstad Ø, Ariansen I (2023)
National health registries - a 'goldmine' for studying non-communicable disease occurrence in Norway - the NCDNOR project
Scand J Public Health, 14034948231214580 (in press)
DOI 10.1177/14034948231214580, PubMed 38073227

Rognli EB, Heiberg IH, Jacobsen BK, Høye A, Bramness JG (2023)
Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder
Am J Psychiatry, 180 (6), 437-444
DOI 10.1176/appi.ajp.22010076, PubMed 37132221

Stelander LT, Lorem GF, Høye A, Bramness JG, Wynn R, Grønli OK (2023)
The effects of exceeding low-risk drinking thresholds on self-rated health and all-cause mortality in older adults: the Tromsø study 1994-2020
Arch Public Health, 81 (1), 25
DOI 10.1186/s13690-023-01035-0, PubMed 36797780

Publications 2022

Bolstad I, Alakokkare AE, Bramness JG, Rognli EB, Levola J, Mustonen A, Miettunen J, Niemelä S (2022)
The relationships between use of alcohol, tobacco and coffee in adolescence and mood disorders in adulthood
Acta Psychiatr Scand, 146 (6), 594-603
DOI 10.1111/acps.13506, PubMed 36177725

Bolstad I, Toft H, Lien L, Moe JS, Rolland B, Bramness JG (2022)
Longitudinal determinants of insomnia among patients with alcohol use disorder
Alcohol, 108, 10-20
DOI 10.1016/j.alcohol.2022.11.002, PubMed 36356647

Bondø P, Høye A, Løchen ML, Bramness JG (2022)
The relationship between smokeless tobacco (snus) and anxiety and depression among adults and elderly people. A comparison to smoking in the Tromsø Study
Addiction, 117 (10), 2695-2706
DOI 10.1111/add.15950, PubMed 35603916

Bramness JG (2022)
[Antidepressants are not addictive]
Tidsskr Nor Laegeforen, 142 (13)
DOI 10.4045/tidsskr.22.0562, PubMed 36164795

Bramness JG, Pandey S, Moe JS, Toft H, Lien L, Bolstad I (2022)
History of Delirium Tremens in AUD Patients in Treatment: Relationship to AUD Severity and Other Factors
Subst Abuse Rehabil, 13, 65-72
DOI 10.2147/SAR.S361810, PubMed 36124240

Bramness JG, Skulberg KR, Skulberg A, Skulberg A (2022)
Blood alcohol levels after standardized intake of alcohol are related to measured blood phosphate levels
Clin Biochem, 109-110, 90-93
DOI 10.1016/j.clinbiochem.2022.08.006, PubMed 35973618

Chalabianloo F, Høiseth G, Vold JH, Johansson KA, Kringen MK, Dalgard O, Ohldieck C, Druckrey-Fiskaaen KT, Aas C, Løberg EM, Bramness JG, Fadnes LT (2022)
Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations
J Addict Dis, 41 (1), 53-63
DOI 10.1080/10550887.2022.2057140, PubMed 35356868

Lespine LF, Bramness JG, Pignon B, Vaiva G, Thomas P, Roelandt JL, Benradia I, Amad A, Geoffroy PA, Rolland B (2022)
Gender-related associations between psychiatric disorders and alcohol use disorder: Findings from the french "Mental health in the general population" survey
Arch Womens Ment Health, 25 (5), 895-902
DOI 10.1007/s00737-022-01253-5, PubMed 36083520

Levola J, Denisoff A, Mustonen A, Alakokkare AE, Miettunen J, Bramness JG, Niemelä S (2022)
Associations of Adolescent Alcohol Use and Self-Reported Alcohol Tolerance With Risk of Self-Harm and Suicide in Early Adulthood: A Birth-Cohort Study
J Stud Alcohol Drugs, 84 (2), 198-207
DOI 10.15288/jsad.22-00055, PubMed 36971713

Myhre MØ, Walby FA, Bramness JG, Mehlum L (2022)
Trajectories of Service Contact before Suicide in People with Substance Use Disorders-A National Register Study
Arch Suicide Res, 28 (1), 200-215
DOI 10.1080/13811118.2022.2151959, PubMed 36472383

Mørland J, Bretteville-Jensen AL, Bramness JG (2022)
On the duration of cannabis effects and the presence of THC in the body
Addiction, 118 (2), 390-391
DOI 10.1111/add.16080, PubMed 36331427

Pandey S, Bolstad I, Lien L, Walby FA, Myhre MØ, Bramness JG (2022)
Sex-specific factors associated with lifetime suicide attempt among patients with alcohol use disorders
BJPsych Open, 8 (4), e135
DOI 10.1192/bjo.2022.545, PubMed 35848151

Rognli EB, Taipale H, Hjorthøj C, Mittendorfer-Rutz E, Bramness JG, Heiberg IH, Niemelä S (2022)
Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016
Psychol Med, 53 (11), 5246-5255
DOI 10.1017/S003329172200229X, PubMed 35983644

Stelander LT, Høye A, Bramness JG, Wynn R, Grønli OK (2022)
Sex differences in at-risk drinking and associated factors-a cross-sectional study of 8,616 community-dwelling adults 60 years and older: the Tromsø study, 2015-16
BMC Geriatr, 22 (1), 170
DOI 10.1186/s12877-022-02842-w, PubMed 35232388

Toft H, Bramness JG, Lien L (2022)
Levels of Peripheral Circulating IL-6 and IL-10 Decrease Over Time Despite High Depression Burden in PTSD Patients
Neuropsychiatr Dis Treat, 18, 737-747
DOI 10.2147/NDT.S357797, PubMed 35414745

Publications 2021

Abebe DS, Lien L, Bramness JG (2021)
Effects of age and gender on the relationship between alcohol use disorder and somatic diseases: a national register study in Norway
BMJ Open, 11 (11), e050608
DOI 10.1136/bmjopen-2021-050608, PubMed 34758993

Bolstad I, Lien L, Bramness JG (2021)
ADHD symptoms as risk factor for PTSD in inpatients treated for alcohol use disorder
Psychiatry Res, 300, 113904
DOI 10.1016/j.psychres.2021.113904, PubMed 33872853

Bramness JG, Bye EK, Moan IS, Rossow I (2021)
Alcohol Use during the COVID-19 Pandemic: Self-Reported Changes and Motives for Change
Eur Addict Res, 27 (4), 257-262
DOI 10.1159/000515102, PubMed 33839730

Bramness JG, Hjellvik V, Stubhaug A, Skurtveit S (2021)
Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database
Basic Clin Pharmacol Toxicol, 130 (1), 84-92
DOI 10.1111/bcpt.13660, PubMed 34559439

Chalabianloo F, Fadnes LT, Høiseth G, Ohldieck C, Vold JH, Aas C, Løberg EM, Johansson KA, Bramness JG (2021)
Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
Subst Abuse Treat Prev Policy, 16 (1), 39
DOI 10.1186/s13011-021-00367-w, PubMed 33941217

Holdø I, Bramness JG, Handal M, Hansen BH, Hjellvik V, Skurtveit S (2021)
Association Between Prescribed Hypnotics in Infants and Toddlers and Later ADHD: A Large Cohort Study from Norway
Child Psychiatry Hum Dev, 52 (4), 533-543
DOI 10.1007/s10578-020-01039-9, PubMed 32772207

Høye A, Jacobsen BK, Bramness JG, Nesvåg R, Reichborn-Kjennerud T, Heiberg I (2021)
Total and cause-specific mortality in patients with personality disorders: the association between comorbid severe mental illness and substance use disorders
Soc Psychiatry Psychiatr Epidemiol, 56 (10), 1809-1819
DOI 10.1007/s00127-021-02055-3, PubMed 33677644

Høye A, Jacobsen BK, Bramness JG, Nesvåg R, Reichborn-Kjennerud T, Heiberg I (2021)
Correction to: Total and cause-specific mortality in patients with personality disorders: the association between comorbid severe mental illness and substance use disorders
Soc Psychiatry Psychiatr Epidemiol, 56 (10), 1821
DOI 10.1007/s00127-021-02124-7, PubMed 34196744

Lien IA, Bolstad I, Lien L, Bramness JG (2021)
Screening for depression in patients in treatment for alcohol use disorder using the Beck Depression Inventory-II and the Hopkins Symptom Checklist-10
Psychiatry Res, 308, 114363
DOI 10.1016/j.psychres.2021.114363, PubMed 34979381

Lien L, Bolstad I, Bramness JG (2021)
Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life
BMC Psychiatry, 21 (1), 244
DOI 10.1186/s12888-021-03252-9, PubMed 33975577

Moe JS, Bolstad I, Mørland JG, Bramness JG (2021)
GABA_A subunit single nucleotide polymorphisms show sex-specific association to alcohol consumption and mental distress in a Norwegian population-based sample
Psychiatry Res, 307, 114257
DOI 10.1016/j.psychres.2021.114257, PubMed 34852975

Oerbeck B, Overgaard KR, Hjellvik V, Lien L, Bramness JG (2021)
The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
J Child Adolesc Psychopharmacol, 31 (5), 350-357
DOI 10.1089/cap.2020.0123, PubMed 33635152

Pandey S, Bolstad I, Lien L, Bramness JG (2021)
Antisocial Personality Disorder Among Patients in Treatment for Alcohol Use Disorder (AUD): Characteristics and Predictors of Early Relapse or Drop-Out
Subst Abuse Rehabil, 12, 11-22
DOI 10.2147/SAR.S296526, PubMed 33907489

Pandey S, Bolstad I, Lien L, Bramness JG (2021)
Factors associated with the level of prolactin in patients under remission from Alcohol Use Disorder: A gender perspective
Neuropsychopharmacol Rep, 41 (3), 352-361
DOI 10.1002/npr2.12182, PubMed 33961352

Rognli EB, Bramness JG, von Soest T (2021)
Smoking in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, antidepressants and anxiolytics
Psychol Med, 52 (14), 3241-3250
DOI 10.1017/S0033291720005401, PubMed 33583454

Rossow I, Bye EK, Moan IS, Kilian C, Bramness JG (2021)
Changes in Alcohol Consumption during the COVID-19 Pandemic-Small Change in Total Consumption, but Increase in Proportion of Heavy Drinkers
Int J Environ Res Public Health, 18 (8)
DOI 10.3390/ijerph18084231, PubMed 33923567

Stelander LT, Høye A, Bramness JG, Selbæk G, Lunde LH, Wynn R, Grønli OK (2021)
The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Tromsø study, 1994-2016
Subst Abuse Treat Prev Policy, 16 (1), 45
DOI 10.1186/s13011-021-00376-9, PubMed 34039389

Toft H, Bramness J, Tilden T, Bolstad I, Lien L (2021)
Persistent level of mental distress in PTSD patients is not reflected in cytokine levels 1 year after the treatment
Acta Neuropsychiatr, 33 (5), 254-260
DOI 10.1017/neu.2021.11, PubMed 33902770

Publications 2020

Andersen N, Bramness JG, Lund IO (2020)
The emerging COVID-19 research: dynamic and regularly updated science maps and analyses
BMC Med Inform Decis Mak, 20 (1), 309
DOI 10.1186/s12911-020-01321-9, PubMed 33256719

Bramness JG, Bretteville-Jensen AL (2020)
[Cannabis – riskier than we thought?]
Tidsskr Nor Laegeforen, 140 (18)
DOI 10.4045/tidsskr.20.0801, PubMed 33322880

Bramness JG, Bretteville-Jensen AL (2020)
Cannabis - more dangerous than we thought?
Tidsskr. Nor. Laegeforen., 140 (18), 1845

Bramness JG, Malt UF (2020)
[Gradual dose reduction of antipsychotic drugs]
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0322, PubMed 32602326

Bramness JG, Malt UF (2020)
Reduction of antipsychotic drugs
Tidsskr. Nor. Laegeforen., 140 (10), 979

Drummond C, Hillyard M, Leonhardt M, Wurst F, Dom G, Mann K, Bramness JG (2020)
Comparison of European Clinical Guidelines on the Management of Alcohol Use Disorders
Eur Addict Res, 27 (3), 227-236
DOI 10.1159/000512112, PubMed 33291106

Gabrhelík R, Mahic M, Lund IO, Bramness J, Selmer R, Skovlund E, Handal M, Skurtveit S (2020)
Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study
Eur Addict Res, 27 (2), 131-141
DOI 10.1159/000510821, PubMed 33040062

Guldal I, Bramness JG (2020)
Clinical Communication Handbook Oslo: Norwegian Association for General Medicine
Tidsskr. Nor. Laegeforen., 140 (6), 600

Heiberg IH, Nesvåg R, Balteskard L, Bramness JG, Hultman CM, Naess Ø, Reichborn-Kjennerud T, Ystrom E, Jacobsen BK, Høye A (2020)
Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness
Acta Psychiatr Scand, 141 (5), 439-451
DOI 10.1111/acps.13157, PubMed 32022895

Hjemsæter AJ, Bramness JG, Drake R, Skeie I, Monsbakken B, Benth JŠ, Landheim AS (2020)
Levels of mental distress over 18 years after entering treatment for substance use disorders: A longitudinal cohort study
Nordisk Alkohol Nark, 37 (4), 352-364
DOI 10.1177/1455072520947249, PubMed 35310926

Johnson SU, Hoffart A, Tilden T, Toft H, Neupane SP, Lien L, Bramness JG (2020)
Circulating cytokine levels in the treatment of comorbid anxiety disorders
Acta Neuropsychiatr, 33 (2), 65-71
DOI 10.1017/neu.2020.38, PubMed 33109296

Mørland J, Bramness JG (2020)
Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users
Forensic Sci Int, 309, 110188
DOI 10.1016/j.forsciint.2020.110188, PubMed 32120192

Oerbeck B, Overgaard KR, Hjellvik V, Bramness JG, Hansen BH, Lien L (2020)
The Use of Sleep Medication in Youth Residential Care
J Child Adolesc Psychopharmacol, 30 (5), 335-341
DOI 10.1089/cap.2019.0172, PubMed 31976753

Wangensteen T, Halsa A, Bramness JG (2020)
Creating meaning to substance use problems: a qualitative study with patients in treatment and their children
J. Subst. Use, 25 (4), 382-386
DOI 10.1080/14659891.2020.1715497

Publications 2019

Bjørkhaug ST, Neupane SP, Bramness JG, Aanes H, Skar V, Medhus AW, Valeur J (2019)
Plasma cytokine levels in patients with chronic alcohol overconsumption: Relations to gut microbiota markers and clinical correlates
Alcohol, 85, 35-40
DOI 10.1016/j.alcohol.2019.10.002, PubMed 31610228

Bjørkhaug ST, Aanes H, Neupane SP, Bramness JG, Malvik S, Henriksen C, Skar V, Medhus AW, Valeur J (2019)
Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption
Gut Microbes, 10 (6), 663-675
DOI 10.1080/19490976.2019.1580097, PubMed 30894059

Bramness JG (2019)
[No easy access to health data]
Tidsskr Nor Laegeforen, 139 (8)
DOI 10.4045/tidsskr.19.0234, PubMed 31062559

Bramness JG (2019)
Access to health data is not easy
Tidsskr. Nor. Laegeforen., 139 (8), 690

Bramness JG, Vindenes V (2019)
[Medical cannabis]
Tidsskr Nor Laegeforen, 139 (15)
DOI 10.4045/tidsskr.19.0595, PubMed 31642634

Bramness JG, Vindenes V (2019)
Medical cannabis
Tidsskr. Nor. Laegeforen., 139 (15), 1437

Bramness JG, von Soest T (2019)
A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults
BMC Pulm Med, 19 (1), 52
DOI 10.1186/s12890-019-0814-x, PubMed 30808319

Chalabianloo F, Westin AA, Skogvoll E, Bramness JG, Spigset O (2019)
Methadone serum concentrations and influencing factors: A naturalistic observational study
Psychopharmacology (Berl), 236 (11), 3159-3167
DOI 10.1007/s00213-019-05277-1, PubMed 31139877

Heiberg IH, Jacobsen BK, Balteskard L, Bramness JG, Naess Ø, Ystrom E, Reichborn-Kjennerud T, Hultman CM, Nesvåg R, Høye A (2019)
Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness
Acta Psychiatr Scand, 139 (6), 558-571
DOI 10.1111/acps.13017, PubMed 30844079

Hjemsæter AJ, Bramness JG, Drake R, Skeie I, Monsbakken B, Benth JŠ, Landheim AS (2019)
Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study
BMC Psychiatry, 19 (1), 101
DOI 10.1186/s12888-019-2077-8, PubMed 30922325

Rognli EB, Bramness JG, von Soest T (2019)
Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants
Acta Psychiatr Scand, 141 (2), 149-156
DOI 10.1111/acps.13104, PubMed 31560790

Shestopal I, Bramness JG (2019)
Effect of Hypnotherapy in Alcohol Use Disorder Compared With Motivational Interviewing: A Randomized Controlled Trial
Addict. Disord. Treat., 18 (3), 169-175
DOI 10.1097/ADT.0000000000000170

Toft H, Lien L, Neupane SP, Abebe DS, Tilden T, Wampold BE, Bramness JG (2019)
Cytokine concentrations are related to level of mental distress in inpatients not using anti-inflammatory drugs
Acta Neuropsychiatr, 32 (1), 23-31
DOI 10.1017/neu.2019.36, PubMed 31576798

Torvik FA, Rosenström TH, Gustavson K, Ystrom E, Kendler KS, Bramness JG, Czajkowski N, Reichborn-Kjennerud T (2019)
Explaining the association between anxiety disorders and alcohol use disorder: A twin study
Depress Anxiety, 36 (6), 522-532
DOI 10.1002/da.22886, PubMed 30838764

Wangensteen T, Bramness JG, Halsa A (2019)
Growing up with parental substance use disorder: The struggle with complex emotions, regulation of contact, and lack of professional support
Child Fam. Soc. Work, 24 (2), 201-208
DOI 10.1111/cfs.12603

Weibell MA, Johannessen JO, Auestad B, Bramness J, Brønnick K, Haahr U, Joa I, Larsen TK, Melle I, Opjordsmoen S, Rund BR, Røssberg JI, Simonsen E, Vaglum P, Stain H, Friis S, Hegelstad WTV (2019)
Early Substance Use Cessation Improves Cognition-10 Years Outcome in First-Episode Psychosis Patients
Front Psychiatry, 10, 495
DOI 10.3389/fpsyt.2019.00495, PubMed 31354551

Publications 2018

Abel KF, Skjærvø I, Ravndal E, Clausen T, Bramness JG (2018)
Perceived Self-Control is Related to Mental Distress in Patients Entering Substance Use Disorder Treatment
Subst Use Misuse, 53 (9), 1454-1462
DOI 10.1080/10826084.2017.1413114, PubMed 29303399

Bramness JG (2018)
About LSD in the reading room, farmers and proportions
Tidsskr. Nor. Laegeforen., 138 (2), 106

Bramness JG, Dom G, Gual A, Mann K, Wurst FM (2018)
A Survey on the Medical Use of Cannabis in Europe: A Position Paper
Eur Addict Res, 24 (4), 201-205
DOI 10.1159/000492757, PubMed 30134238

Gjerden P, Bramness JG, Slordal L (2018)
Kvetiapine is used a lot
Tidsskr. Nor. Laegeforen., 138 (13), 1225-1226

Gjerden P, Bramness JG, Slørdal L (2018)
[Not Available]
Tidsskr Nor Laegeforen, 138 (13)
DOI 10.4045/tidsskr.18.0535, PubMed 30180497

Heiberg IH, Jacobsen BK, Nesvåg R, Bramness JG, Reichborn-Kjennerud T, Næss Ø, Ystrom E, Hultman CM, Høye A (2018)
Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder
PLoS One, 13 (8), e0202028
DOI 10.1371/journal.pone.0202028, PubMed 30138449

Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG (2018)
[Use of drugs for alcohol use disorder in Norway 2004–16]
Tidsskr Nor Laegeforen, 138 (18)
DOI 10.4045/tidsskr.18.0383, PubMed 30421743

Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG (2018)
Use of drugs for alcoholic disorders in Norway 2004-16
Tidsskr. Nor. Laegeforen., 138 (18), 1710-1715

Martinez P, Lien L, Zemore S, Bramness JG, Neupane SP (2018)
Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders
J Neuroimmunol, 318, 80-86
DOI 10.1016/j.jneuroim.2018.02.011, PubMed 29500107

Morland J, Bramness JG (2018)
Misleading about cannabis and traffic hazard Reply
Tidsskr. Nor. Laegeforen., 138 (2), 112

Nesvåg R, Bramness JG, Handal M, Hartz I, Hjellvik V, Skurtveit S (2018)
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents
Eur Psychiatry, 49, 16-22
DOI 10.1016/j.eurpsy.2017.12.009, PubMed 29366845

Skurtveit S, Bramness JG, Hjellvik V, Hartz I, Nesvåg R, Hauge LJ, Handal M (2018)
Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents
Acta Psychiatr Scand, 137 (5), 413-421
DOI 10.1111/acps.12877, PubMed 29623693

Toft H, Bramness JG, Lien L, Abebe DS, Wampold BE, Tilden T, Hestad K, Neupane SP (2018)
PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress
Neuropsychiatr Dis Treat, 14, 2367-2378
DOI 10.2147/NDT.S173659, PubMed 30271153

Toft H, Neupane SP, Bramness JG, Tilden T, Wampold BE, Lien L (2018)
The effect of trauma and alcohol on the relationship between level of cytokines and depression among patients entering psychiatric treatment
BMC Psychiatry, 18 (1), 95
DOI 10.1186/s12888-018-1677-z, PubMed 29631540

Wiig EM, Halsa A, Bramness J, Myra SM, Haugland BSM (2018)
Rescue the child or treat the adult? Understandings among professionals in dual treatment of substance-use disorders and parenting
Nordisk Alkohol Nark, 35 (3), 179-195
DOI 10.1177/1455072518773615, PubMed 32934526

Publications 2017

Bjørkhaug ST, Skar V, Medhus AW, Tollisen A, Bramness JG, Valeur J (2017)
Chronic alcohol overconsumption may alter gut microbial metabolism: a retrospective study of 719 ¹³C-D-xylose breath test results
Microb Ecol Health Dis, 28 (1), 1301725
DOI 10.1080/16512235.2017.1301725, PubMed 28572752

Engh JA, Bramness JG (2017)
Psychosis relapse, medication non-adherence, and cannabis
Lancet Psychiatry, 4 (8), 578-579
DOI 10.1016/S2215-0366(17)30254-7, PubMed 28705599

Fiksdal Abel K, Ravndal E, Clausen T, Bramness JG (2017)
Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment
Eur Addict Res, 23 (6), 298-305
DOI 10.1159/000484240, PubMed 29320768

Gjerden P, Bramness JG, Tvete IF, Slørdal L (2017)
The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015
Eur J Clin Pharmacol, 73 (9), 1173-1179
DOI 10.1007/s00228-017-2281-8, PubMed 28623386

Gjersing L, Jonassen K, Skurtveit S, Bramness J, Clausen T (2017)
Emergency service use is common in the year before death among drug users who die from an overdose
J. Subst. Use, 22 (3), 331-336
DOI 10.1080/14659891.2016.1208778

Holdø I, Bramness JG, Handal M, Torgersen L, Reichborn-Kjennerud T, Ystrøm E, Nordeng H, Skurtveit S (2017)
Hypnotics use in children 0-18 months: moderate agreement between mother-reported survey data and prescription registry data
J Pharm Policy Pract, 10, 28
DOI 10.1186/s40545-017-0117-7, PubMed 28904801

Kringen MK, Chalabianloo F, Bernard JP, Bramness JG, Molden E, Høiseth G (2017)
Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment
Ther Drug Monit, 39 (5), 550-555
DOI 10.1097/FTD.0000000000000437, PubMed 28723731

Morland J, Bramness JG (2017)
Effects of cannabis last longer than estimated
Tidsskr. Nor. Laegeforen., 137 (20), 1589-1591

Nesvåg R, Reichborn-Kjennerud T, Gillespie NA, Knudsen GP, Bramness JG, Kendler KS, Ystrom E (2017)
Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins
Schizophr Bull, 43 (3), 644-653
DOI 10.1093/schbul/sbw101, PubMed 27431873

Neupane SP, Bramness JG, Lien L (2017)
Comorbid post-traumatic stress disorder in alcohol use disorder: relationships to demography, drinking and neuroimmune profile
BMC Psychiatry, 17 (1), 312
DOI 10.1186/s12888-017-1479-8, PubMed 28851339

Salvatore S, Bramness JG, Røislien J (2017)
Erratum to: Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
BMC Med Res Methodol, 17 (1), 34
DOI 10.1186/s12874-017-0311-y, PubMed 28231768

Torvik FA, Ystrom E, Gustavson K, Rosenström TH, Bramness JG, Gillespie N, Aggen SH, Kendler KS, Reichborn-Kjennerud T (2017)
Diagnostic and genetic overlap of three common mental disorders in structured interviews and health registries
Acta Psychiatr Scand, 137 (1), 54-64
DOI 10.1111/acps.12829, PubMed 29072781

Weibell MA, Hegelstad WTV, Auestad B, Bramness J, Evensen J, Haahr U, Joa I, Johannessen JO, Larsen TK, Melle I, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T, McGorry P, Friis S (2017)
The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis
Schizophr Bull, 43 (4), 843-851
DOI 10.1093/schbul/sbw179, PubMed 28199703

Publications 2016

Baz-Lomba JA, Salvatore S, Gracia-Lor E, Bade R, Castiglioni S, Castrignanò E, Causanilles A, Hernandez F, Kasprzyk-Hordern B, Kinyua J, McCall AK, van Nuijs A, Ort C, Plósz BG, Ramin P, Reid M, Rousis NI, Ryu Y, de Voogt P, Bramness J, Thomas K (2016)
Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities
BMC Public Health, 16 (1), 1035
DOI 10.1186/s12889-016-3686-5, PubMed 27716139

Bramness JG (2016)
A better life Stories, experiences and research on the recovery of drug addiction and mental health problems
Tidsskr. Nor. Laegeforen., 136 (20), 1746
DOI 10.4045/tidsskr.16.0767

Bramness JG, Mann K, Wurst FM (2016)
Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe
Eur Addict Res, 22 (6), 318-321
DOI 10.1159/000447965, PubMed 27438908

Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O (2016)
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
PLoS One, 11 (11), e0166451
DOI 10.1371/journal.pone.0166451, PubMed 27846264

Nesvåg R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S (2016)
Mental disorder diagnoses among children and adolescents who use antipsychotic drugs
Eur Neuropsychopharmacol, 26 (9), 1412-1418
DOI 10.1016/j.euroneuro.2016.07.001, PubMed 27452144

Neupane SP, Skulberg A, Skulberg KR, Aass HC, Bramness JG (2016)
Cytokine Changes following Acute Ethanol Intoxication in Healthy Men: A Crossover Study
Mediators Inflamm, 2016, 3758590
DOI 10.1155/2016/3758590, PubMed 28090151

Rognli EB, Bramness JG, Skurtveit S, Bukten A (2016)
Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
J Subst Abuse Treat, 74, 42-47
DOI 10.1016/j.jsat.2016.12.007, PubMed 28132699

Ryu Y, Gracia-Lor E, Bade R, Baz-Lomba JA, Bramness JG, Castiglioni S, Castrignanò E, Causanilles A, Covaci A, de Voogt P, Hernandez F, Kasprzyk-Hordern B, Kinyua J, McCall AK, Ort C, Plósz BG, Ramin P, Rousis NI, Reid MJ, Thomas KV (2016)
Increased levels of the oxidative stress biomarker 8-iso-prostaglandin F_2α in wastewater associated with tobacco use
Sci Rep, 6, 39055
DOI 10.1038/srep39055, PubMed 27976726

Salvatore S, Bramness JG, Røislien J (2016)
Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
BMC Med Res Methodol, 16, 81
DOI 10.1186/s12874-016-0179-2, PubMed 27406032

Salvatore S, Froslie KF, Roislien J, Zuccato E, Castiglioni S, Bramness JG (2016)
A nuanced picture of illicit drug use in 17 Italian cities through functional principal component analysis of temporal wastewater data
J. Public Health-Heidelberg, 24 (3), 165-174
DOI 10.1007/s10389-016-0717-8

Salvatore S, Røislien J, Baz-Lomba JA, Bramness JG (2016)
Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data
Pharmacoepidemiol Drug Saf, 26 (3), 320-326
DOI 10.1002/pds.4127, PubMed 27862608

Tjagvad C, Skurtveit S, Bramness JG, Gjersing L, Gossop M, Clausen T (2016)
Misuse of prescription drugs and overdose deaths
J. Subst. Use, 21 (5), 515-520
DOI 10.3109/14659891.2015.1077280

Tveter AL, Bakken TL, Rossberg JI, Bech-Pedersen E, Bramness JG (2016)
Short communication: reliability and validity of the UKU Side Effect Rating Scale for adults with intellectual disabilities
Adv. Ment. Health Intellet. Disabil., 10 (3), 166-171
DOI 10.1108/AMHID-10-2015-0051

van Wel JH, Gracia-Lor E, van Nuijs AL, Kinyua J, Salvatore S, Castiglioni S, Bramness JG, Covaci A, Van Hal G (2016)
Investigation of agreement between wastewater-based epidemiology and survey data on alcohol and nicotine use in a community
Drug Alcohol Depend, 162, 170-5
DOI 10.1016/j.drugalcdep.2016.03.002, PubMed 26980372

van Wel JH, Kinyua J, van Nuijs AL, Salvatore S, Bramness JG, Covaci A, Van Hal G (2016)
A comparison between wastewater-based drug data and an illicit drug use survey in a selected community
Int J Drug Policy, 34, 20-6
DOI 10.1016/j.drugpo.2016.04.003, PubMed 27450319

Publications 2015

Bramness JG (2015)
Prevention and treatment of drug addictions An introduction
Tidsskr. Nor. Laegeforen., 135 (2), 155
DOI 10.4045/tidsskr.14.1294

Bramness JG (2015)
Handbook of cannabis
Tidsskr. Nor. Laegeforen., 135 (6), 577
DOI 10.4045/tidsskr.14.1511

Bramness JG (2015)
Patient Injury A thriller about the addictive drugs
Tidsskr. Nor. Laegeforen., 135 (19), 1768
DOI 10.4045/tidsskr.15.0787

Bramness JG, Henriksen B, Person O, Mann K (2015)
Reply: To PMID 23921359
Eur Addict Res, 21 (1), 32
PubMed 25621344

Bramness JG, Henriksen B, Person O, Mann K (2015)
Bibliographic Searches for a Bibliometric Analysis on Drug Addiction Reply
Eur. Addict. Res., 21 (1), 32

Bramness JG, Walby FA, Morken G, Røislien J (2015)
Analyzing Seasonal Variations in Suicide With Fourier Poisson Time-Series Regression: A Registry-Based Study From Norway, 1969-2007
Am J Epidemiol, 182 (3), 244-54
DOI 10.1093/aje/kwv064, PubMed 26081677

Bramness JG, Walby FA, Morken G, Røislien J (2015)
The authors reply
Am J Epidemiol, 182 (9), 820-1
DOI 10.1093/aje/kwv210, PubMed 26429999

Eikemo M, Bramness JG (2015)
Drugs, addiction, and the brain
Tidsskr. Nor. Laegeforen., 135 (9), 876
DOI 10.4045/tidsskr.15.0221

Martinez P, Neupane SP, Perlestenbakken B, Toutoungi C, Bramness JG (2015)
The association between alcohol use and depressive symptoms across socioeconomic status among 40- and 45-year-old Norwegian adults
BMC Public Health, 15, 1146
DOI 10.1186/s12889-015-2479-6, PubMed 26585028

Medhus S, Rognli EB, Gossop M, Holm B, Mørland J, Bramness JG (2015)
Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample
Am J Addict, 24 (7), 586-9
DOI 10.1111/ajad.12274, PubMed 26332037

Nesvåg R, Bramness JG, Ystrom E, Suzanne Krebs T, Johansen PØ (2015)
The link between use of psychedelic drugs and mental health problems
J Psychopharmacol, 29 (9), 1035-6
DOI 10.1177/0269881115596156, PubMed 26395581

Neupane SP, Lien L, Martinez P, Hestad K, Bramness JG (2015)
The relationship of alcohol use disorders and depressive symptoms to tryptophan metabolism: cross-sectional data from a Nepalese alcohol treatment sample
Alcohol Clin Exp Res, 39 (3), 514-21
DOI 10.1111/acer.12651, PubMed 25639711

Neupane SP, Lien L, Ueland T, Mollnes TE, Aukrust P, Bramness JG (2015)
Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders
Alcohol, 49 (5), 471-8
DOI 10.1016/j.alcohol.2015.01.012, PubMed 25873205

Rognli EB, Berge J, Håkansson A, Bramness JG (2015)
Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users
Schizophr Res, 168 (1-2), 185-90
DOI 10.1016/j.schres.2015.08.032, PubMed 26359848

Rossow I, Bramness JG (2015)
The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study
BMC Public Health, 15, 288
DOI 10.1186/s12889-015-1615-7, PubMed 25885781

Salvatore S, Bramness JG, Reid MJ, Thomas KV, Harman C, Røislien J (2015)
Wastewater-Based Epidemiology of Stimulant Drugs: Functional Data Analysis Compared to Traditional Statistical Methods
PLoS One, 10 (9), e0138669
DOI 10.1371/journal.pone.0138669, PubMed 26394227

Skrede S, Tvete IF, Tanum L, Steen VM, Bramness JG (2015)
Incident users of antipsychotic agents and future use of cholesterol-lowering drugs: an observational, pharmacoepidemiologic study
J Clin Psychiatry, 76 (1), e111-6
DOI 10.4088/JCP.14m08996, PubMed 25650676

Tveito M, Correll CU, Bramness JG, Engedal K, Lorentzen B, Refsum H, Høiseth G (2015)
Correlates of major medication side effects interfering with daily performance: results from a cross-sectional cohort study of older psychiatric patients
Int Psychogeriatr, 28 (2), 331-40
DOI 10.1017/S1041610215001544, PubMed 26412479

Publications 2014

Abel KF, Bramness JG, Martinsen EW (2014)
Stimulant medication for ADHD in opioid maintenance treatment
J Dual Diagn, 10 (1), 32-8
DOI 10.1080/15504263.2013.867657, PubMed 25392060

Bramness JG, Reid MJ, Solvik KF, Vindenes V (2014)
Recent trends in the availability and use of amphetamine and methamphetamine in Norway
Forensic Sci Int, 246, 92-7
DOI 10.1016/j.forsciint.2014.11.010, PubMed 25485948

Neupane SP, Bramness JG (2014)
Who seeks treatment for alcohol problems? Demography and alcohol-use characteristics of patients in taboo and non-taboo drinking groups attending professional alcohol services in Nepal
Asian J Psychiatr, 12, 82-7
DOI 10.1016/j.ajp.2014.06.017, PubMed 25440566

Neupane SP, Lien L, Martinez P, Aukrust P, Ueland T, Mollnes TE, Hestad K, Bramness JG (2014)
High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders
CNS Neurosci Ther, 20 (10), 898-904
DOI 10.1111/cns.12303, PubMed 24995667

Rognli EB, Håkansson A, Berge J, Bramness JG (2014)
Does the pattern of amphetamine use prior to incarceration predict later psychosis?--a longitudinal study of amphetamine users in the Swedish criminal justice system
Drug Alcohol Depend, 143, 219-24
DOI 10.1016/j.drugalcdep.2014.07.037, PubMed 25146382

Tveito M, Bramness JG, Engedal K, Lorentzen B, Refsum H, Høiseth G (2014)
Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations
Eur J Clin Pharmacol, 70 (9), 1139-45
DOI 10.1007/s00228-014-1720-z, PubMed 25031073

Tveito M, Lorentzen B, Engedal K, Tanum L, Bramness JG, Refsum H, Høiseth G (2014)
Changes in cognitive function during psychogeriatric treatment in relation to benzodiazepine cessation
Pharmacopsychiatry, 47 (4-5), 145-50
DOI 10.1055/s-0034-1381982, PubMed 24936805

Tveter AL, Bakken TL, Bramness JG, Rossberg JI (2014)
Adjustment of the UKU Side Effect Rating Scale for adults with intellectual disabilities. A pilot study
Adv. Ment. Health Intellet. Disabil., 8 (4), 260-267
DOI 10.1108/AMHID-11-2013-0064

Publications 2013

Bramness JG, Henriksen B, Person O, Mann K (2013)
A bibliometric analysis of European versus USA research in the field of addiction. Research on alcohol, narcotics, prescription drug abuse, tobacco and steroids 2001-2011
Eur Addict Res, 20 (1), 16-22
DOI 10.1159/000348260, PubMed 23921359

Bukten A, Herskedal A, Skurtveit S, Bramness JG, Clausen T (2013)
Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study
Addiction, 108 (11), 1954-61
DOI 10.1111/add.12275, PubMed 23773400

Gjersing L, Jonassen KV, Biong S, Ravndal E, Waal H, Bramness JG, Clausen T (2013)
Diversity in causes and characteristics of drug-induced deaths in an urban setting
Scand J Public Health, 41 (2), 119-25
DOI 10.1177/1403494812472007, PubMed 23302498

Gundersen OH, Mordal J, Berman AH, Bramness JG (2013)
Evaluation of the alcohol use disorders identification test and the drug use disorders identification test among patients at a Norwegian psychiatric emergency ward
Eur Addict Res, 19 (5), 252-60
DOI 10.1159/000343485, PubMed 23548765

Helseth V, Samet S, Johnsen J, Bramness JG, Waal H (2013)
Independent or Substance-Induced Mental Disorders? An Investigation of Comorbidity in an Acute Psychiatric Unit
J. Dual Diagn., 9 (1), 78-86
DOI 10.1080/15504263.2012.749142

Holdø I, Handal M, Skurtveit S, Bramness JG (2013)
Association between prescribing hypnotics for parents and children in Norway
Arch Dis Child, 98 (9), 732-6
DOI 10.1136/archdischild-2013-303646, PubMed 23845695

Høiseth G, Tanum L, Tveito M, Kristiansen KM, Kvande K, Lorentzen B, Refsum H, Bramness J (2013)
A clinical study of the cognitive effects of benzodiazepines in psychogeriatric patients
Pharmacopsychiatry, 46 (6), 209-13
DOI 10.1055/s-0033-1349131, PubMed 23832585

Medhus S, Holm B, Morland J, Bramness JG (2013)
Association Between Methamphetamine Versus Amphetamine and Acute Psychiatric Symptoms
J. Dual Diagn., 9 (4), 292-300
DOI 10.1080/15504263.2013.835161

Mordal J, Medhus S, Holm B, Mørland J, Bramness JG (2013)
Influence of drugs of abuse and alcohol upon patients admitted to acute psychiatric wards: physician's assessment compared to blood drug concentrations
J Clin Psychopharmacol, 33 (3), 415-9
DOI 10.1097/JCP.0b013e31828ec934, PubMed 23609387

Neupane SP, Lien L, Hilberg T, Bramness JG (2013)
Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: a cross-sectional study of inpatients in Nepal
Drug Alcohol Depend, 133 (2), 480-5
DOI 10.1016/j.drugalcdep.2013.07.006, PubMed 23916323

Weibell MA, Joa I, Bramness J, Johannessen JO, McGorry PD, Ten Velden Hegelstad W, Larsen TK (2013)
Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area
BMC Psychiatry, 13, 319
DOI 10.1186/1471-244X-13-319, PubMed 24279887

Westin AA, Bramness JG, Chalabianloo F, Slørdal L (2013)
[A. A. Westin and colleagues reply]
Tidsskr Nor Laegeforen, 133 (10), 1045-6
DOI 10.4045/tidsskr.13.0619, PubMed 23712142

Publications 2012

Bramness JG (2012)
Commentary on Bosker et al. (2012): Driving under the influence of cannabinoids
Addiction, 107 (10), 1845-6
DOI 10.1111/j.1360-0443.2012.03949.x, PubMed 22962959

Bramness JG, Furu K, Skurtveit S, Engeland A (2012)
Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential
Clin Pharmacol Ther, 91 (3), 438-41
DOI 10.1038/clpt.2011.250, PubMed 22318620

Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, Medhus S, Tanum L, Franck J (2012)
Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?
BMC Psychiatry, 12, 221
DOI 10.1186/1471-244X-12-221, PubMed 23216941

Bramness JG, Skurtveit S, Mørland J, Engeland A (2012)
An increased risk of motor vehicle accidents after prescription of methadone
Addiction, 107 (5), 967-72
DOI 10.1111/j.1360-0443.2011.03745.x, PubMed 22151376

Høiseth G, Majid U, Mørland J, Bramness JG, Molden E (2012)
CYP2C19 genetics in fatal carisoprodol intoxications
Eur J Clin Pharmacol, 68 (11), 1561-5
DOI 10.1007/s00228-012-1278-6, PubMed 22527345

Medhus S, Mordal J, Holm B, Mørland J, Bramness JG (2012)
A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards
Psychiatry Res, 206 (1), 17-21
DOI 10.1016/j.psychres.2012.09.023, PubMed 23036490

Neupane SP, Bramness JG (2012)
Prevalence and correlates of major depression among Nepalese patients in treatment for alcohol-use disorders
Drug Alcohol Rev, 32 (2), 170-7
DOI 10.1111/j.1465-3362.2012.00487.x, PubMed 22747513

von Soest T, Bramness JG, Pedersen W, Wichstrøm L (2012)
The relationship between socio-economic status and antidepressant prescription: a longitudinal survey and register study of young adults
Epidemiol Psychiatr Sci, 21 (1), 87-95
DOI 10.1017/s2045796011000722, PubMed 22670416

Publications 2011

Bramness JG, Haugland S (2011)
[Abuse of γ-hydroxybutyrate]
Tidsskr Nor Laegeforen, 131 (21), 2122-5
DOI 10.4045/tidsskr.10.1454, PubMed 22048208

Helland A, Bramness JG (2011)
[Baclofen for alcohol addiction]
Tidsskr Nor Laegeforen, 131 (21), 2132-3
DOI 10.4045/tidsskr.11.0584, PubMed 22048211

Mordal J, Holm B, Gossop M, Romøren M, Mørland J, Bramness J (2011)
Psychoactive substance use among patients admitted to an acute psychiatric ward: laboratory findings and associations with clinical characteristics
Nord J Psychiatry, 65 (3), 208-15
DOI 10.3109/08039488.2010.527014, PubMed 21047195

Publications 2010

Bramness JG (2010)
[Thinking outside the box]
Tidsskr Nor Laegeforen, 130 (4), 386
DOI 10.4045/tidsskr.09.1522, PubMed 20220865

Bramness JG (2010)
[Abuse of pregabalin]
Tidsskr Nor Laegeforen, 130 (17), 1703-4
DOI 10.4045/tidsskr.10.0834, PubMed 20835274

Bramness JG, Clausen T, Duckert F, Ravndal E, Waal H (2010)
Addiction research centres and the nurturing of creativity The Norwegian Centre for Addiction Research (SERAF)
Addiction, 106 (8), 1381-5
DOI 10.1111/j.1360-0443.2010.03086.x, PubMed 20735364

Bramness JG, Khiabani HZ, Mørland J (2010)
Impairment due to cannabis and ethanol: clinical signs and additive effects
Addiction, 105 (6), 1080-7
DOI 10.1111/j.1360-0443.2010.02911.x, PubMed 20331551

Bramness JG, Rossow I (2010)
Can the total consumption of a medicinal drug be used as an indicator of excessive use? The case of carisoprodol
Drug-Educ. Prev. Policy, 17 (2), 168-180
DOI 10.3109/09687630903264278

Bramness JG, Sandvik P, Engeland A, Skurtveit S (2010)
Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database
Basic Clin Pharmacol Toxicol, 107 (5), 883-6
DOI 10.1111/j.1742-7843.2010.00590.x, PubMed 22545971

Bramness JG, Walby FA (2010)
Internet use and suicide among younger age groups between 1989 and 2008 in Japan - Reply
Acta Psychiatr. Scand., 121 (6), 485-486
DOI 10.1111/j.1600-0447.2010.01548.x

Bramness JG, Walby FA, Hjellvik V, Selmer R, Tverdal A (2010)
Self-reported mental health and its gender differences as a predictor of suicide in the middle-aged
Am J Epidemiol, 172 (2), 160-6
DOI 10.1093/aje/kwq091, PubMed 20519262

Gjerde H, Mordal J, Christophersen AS, Bramness JG, Mørland J (2010)
Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device
J Anal Toxicol, 34 (4), 204-9
DOI 10.1093/jat/34.4.204, PubMed 20465866

Gjerden P, Slørdal L, Bramness JG (2010)
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up
Eur J Clin Pharmacol, 66 (9), 911-7
DOI 10.1007/s00228-010-0839-9, PubMed 20521034

Kornør H, Pedersen W, von Soest T, Rossow I, Bramness JG (2010)
[Use of benzodiazepines and cannabis in young adults]
Tidsskr Nor Laegeforen, 130 (9), 928-31
DOI 10.4045/tidsskr.09.0188, PubMed 20453954

Lobmaier P, Gossop M, Waal H, Bramness J (2010)
The pharmacological treatment of opioid addiction--a clinical perspective
Eur J Clin Pharmacol, 66 (6), 537-45
DOI 10.1007/s00228-010-0793-6, PubMed 20169438

Mordal J, Holm B, Mørland J, Bramness JG (2010)
Recent substance intake among patients admitted to acute psychiatric wards: physician's assessment and on-site urine testing compared with comprehensive laboratory analyses
J Clin Psychopharmacol, 30 (4), 455-9
DOI 10.1097/JCP.0b013e3181e61923, PubMed 20631563

Skurtveit S, Furu K, Bramness J, Selmer R, Tverdal A (2010)
Benzodiazepines predict use of opioids--a follow-up study of 17,074 men and women
Pain Med, 11 (6), 805-14
DOI 10.1111/j.1526-4637.2010.00870.x, PubMed 20624237

Waal H, Bramness JG (2010)
[Benzodiazepines to people with substance abuse problems?]
Tidsskr Nor Laegeforen, 130 (6), 610-2
DOI 10.4045/tidsskr.09.0687, PubMed 20349006

Publications 2009

Bramness JG (2009)
[Use of lithium in the Norwegian counties Oslo and Sogn og Fjordane]
Tidsskr Nor Laegeforen, 129 (9), 855-7
DOI 10.4045/tidsskr.08.0276, PubMed 19415083

Bramness JG (2009)
[Adolescents and everyday life pains]
Tidsskr Nor Laegeforen, 129 (15), 1444
DOI 10.4045/tidsskr.09.0691, PubMed 19690589

Bramness JG, Grøholt B, Engeland A, Furu K (2009)
The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study
J Affect Disord, 117 (3), 208-11
DOI 10.1016/j.jad.2009.01.006, PubMed 19189871

Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A (2009)
An increased risk of road traffic accidents after prescriptions of lithium or valproate?
Pharmacoepidemiol Drug Saf, 18 (6), 492-6
DOI 10.1002/pds.1740, PubMed 19326366

Bramness JG, Walby F (2009)
Ecological studies and the big puzzle of falling suicide rates
Acta Psychiatr Scand, 119 (3), 169-70
DOI 10.1111/j.1600-0447.2008.01318.x, PubMed 19178393

Bramness JG, Weitoft GR, Hallas J (2009)
Use of lithium in the adult populations of Denmark, Norway and Sweden
J Affect Disord, 118 (1-3), 224-8
DOI 10.1016/j.jad.2009.01.024, PubMed 19249102

Gjerden P, Slørdal L, Bramness JG (2009)
Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents
Eur J Clin Pharmacol, 65 (12), 1229-35
DOI 10.1007/s00228-009-0696-6, PubMed 19644682

Gjerden P, Slørdal L, Bramness JG (2009)
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine
Br J Clin Pharmacol, 68 (2), 238-42
DOI 10.1111/j.1365-2125.2009.03446.x, PubMed 19694744

Gustavsen I, Al-Sammurraie M, Mørland J, Bramness JG (2009)
Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers
Accid Anal Prev, 41 (3), 462-6
DOI 10.1016/j.aap.2009.01.011, PubMed 19393793

Høiseth G, Karinen R, Sørlid HK, Bramness JG (2009)
The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug
Basic Clin Pharmacol Toxicol, 105 (5), 345-9
DOI 10.1111/j.1742-7843.2009.00459.x, PubMed 19663822

Mordal J, Gundersen O, Bramness JG (2009)
Norwegian version of the Mini-International Neuropsychiatric Interview: feasibility, acceptability and test-retest reliability in an acute psychiatric ward
Eur Psychiatry, 25 (3), 172-7
DOI 10.1016/j.eurpsy.2009.02.004, PubMed 19553089

Skurtveit S, Strøm H, Skrivarhaug T, Mørland J, Bramness JG, Engeland A (2009)
Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study
Diabet Med, 26 (4), 404-8
DOI 10.1111/j.1464-5491.2009.02699.x, PubMed 19388971

Winther RB, Bramness JG (2009)
[Prescription shopping of addictive drugs in Norway]
Tidsskr Nor Laegeforen, 129 (6), 517-20
DOI 10.4045/tidsskr.09.34414, PubMed 19282887

Publications 2008

Bramness JG (2008)
[The Somadril Association in Norway]
Tidsskr Nor Laegeforen, 128 (13), 1545; authorr reply 1545
PubMed 18587468

Bramness JG, Skurtveit S (2008)
Carisoprodol should be taken off the market
South Med J, 101 (10), 1074-5
DOI 10.1097/SMJ.0b013e318184ac60, PubMed 18791514

Bramness JG, Skurtveit S, Gustavsen I, Mørland J (2008)
The absence of evidence is not the same as evidence for absence!
Addiction, 103 (3), 513-4
DOI 10.1111/j.1360-0443.2007.02103.x, PubMed 18269374

Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A (2008)
Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway
J Clin Psychiatry, 69 (7), 1099-103
DOI 10.4088/jcp.v69n0709, PubMed 18588362

Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K (2008)
Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006
Br J Clin Pharmacol, 65 (5), 653-60
DOI 10.1111/j.1365-2125.2008.03102.x, PubMed 18294334

Gjerden P, Bramness JG, Slørdal L (2008)
Effect of warnings in a medical journal on the use of orphenadrine
J Eval Clin Pract, 14 (4), 615-7
DOI 10.1111/j.1365-2753.2007.00912.x, PubMed 18462287

Gjerden P, Bramness JG, Slørdal L (2008)
The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study
Br J Clin Pharmacol, 67 (2), 228-33
DOI 10.1111/j.1365-2125.2008.03342.x, PubMed 19094158

Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Mørland J (2008)
Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam
Sleep Med, 9 (8), 818-22
DOI 10.1016/j.sleep.2007.11.011, PubMed 18226959

Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG (2008)
Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors
Eur J Clin Pharmacol, 65 (3), 295-301
DOI 10.1007/s00228-008-0565-8, PubMed 18810397

Høiseth G, Sørlid HK, Bramness J (2008)
Acute intoxications with carisoprodol
Clin Toxicol (Phila), 46 (4), 307-9
DOI 10.1080/15563650701476953, PubMed 18363125

Khiabani HZ, Mørland J, Bramness JG (2008)
Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis
Eur J Intern Med, 19 (8), 608-12
DOI 10.1016/j.ejim.2007.06.031, PubMed 19046727

Mordal J, Bramness JG, Holm B, Mørland J (2008)
Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence
Gen Hosp Psychiatry, 30 (1), 55-60
DOI 10.1016/j.genhosppsych.2007.10.006, PubMed 18164941

Skurtveit S, Furu K, Bramness JG, Tverdal A (2008)
Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later--a follow-up study of 13,390 men and women aged 40-42 years
Pharmacoepidemiol Drug Saf, 17 (9), 926-933
DOI 10.1002/pds.1616, PubMed 18489010

Slørdal L, Bramness JG (2008)
[Is alimemazine a suitable sleeping agent for children?]
Tidsskr Nor Laegeforen, 128 (19), 2194-6
PubMed 18846144

Publications 2007

Bramness JG, Engeland A, Furu K (2007)
[Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?]
Tidsskr Nor Laegeforen, 127 (20), 2653-5
PubMed 17952146

Bramness JG, Furu K, Engeland A, Skurtveit S (2007)
Carisoprodol use and abuse in Norway: a pharmacoepidemiological study
Br J Clin Pharmacol, 64 (2), 210-8
DOI 10.1111/j.1365-2125.2007.02847.x, PubMed 17298482

Bramness JG, Kornør H (2007)
Benzodiazepine prescription for patients in opioid maintenance treatment in Norway
Drug Alcohol Depend, 90 (2-3), 203-9
DOI 10.1016/j.drugalcdep.2007.03.008, PubMed 17478058

Bramness JG, Sandvik P, Schøyen H, Walby FA (2007)
[Weak report about antidepressive agents from the Knowledge Center]
Tidsskr Nor Laegeforen, 127 (24), 3236-7
PubMed 18084369

Bramness JG, Skurtveit S, Mørland J, Engeland A (2007)
The risk of traffic accidents after prescriptions of carisoprodol
Accid Anal Prev, 39 (5), 1050-5
DOI 10.1016/j.aap.2007.02.002, PubMed 17854578

Bramness JG, Walby FA, Tverdal A (2007)
The sales of antidepressants and suicide rates in Norway and its counties 1980-2004
J Affect Disord, 102 (1-3), 1-9
DOI 10.1016/j.jad.2006.12.002, PubMed 17223200

Hausken AM, Skurtveit S, Rosvold EO, Bramness JG, Furu K (2007)
Psychotropic drug use among persons with mental distress symptoms: a population-based study in Norway
Scand J Public Health, 35 (4), 356-64
DOI 10.1080/14034940601159161, PubMed 17786798

Publications 2006

Bramness JG (2006)
[CYP genotyping in psychopharmacological treatment]
Tidsskr Nor Laegeforen, 126 (4), 480; author reply 480
PubMed 16477294

Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, Rønning M (2006)
[Changes in the sale and use of flunitrazepam in Norway after 1999]
Tidsskr Nor Laegeforen, 126 (5), 589-90
PubMed 16505866

Høiseth G, Bramness JG, Christophersen AS, Mørland J (2006)
Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003
Int J Legal Med, 121 (5), 403-9
DOI 10.1007/s00414-006-0139-1, PubMed 17115170

Høiseth G, Løvåsdal Ø, Titze TK, Bramness JG, Bachs L (2006)
[Psychiatric and cognitive long-term effects of ecstasy]
Tidsskr Nor Laegeforen, 126 (5), 596-8
PubMed 16505868

Khiabani HZ, Bramness JG, Bjørneboe A, Mørland J (2006)
Relationship between THC concentration in blood and impairment in apprehended drivers
Traffic Inj Prev, 7 (2), 111-6
DOI 10.1080/15389580600550172, PubMed 16854704

Mellingsaeter TC, Bramness JG, Slørdal L (2006)
[Are z-hypnotics better and safer sleeping pills than benzodiazepines?]
Tidsskr Nor Laegeforen, 126 (22), 2954-6
PubMed 17117195

Publications 2005

Bramness JG, Hausken AM, Sakshaug S, Skurtveit S, Rønning M (2005)
[Prescription of selective serotonin reuptake inhibitors 1990-2004]
Tidsskr Nor Laegeforen, 125 (18), 2470-3
PubMed 16186862

Bramness JG, Mørland J, Sørlid HK, Rudberg N, Jacobsen D (2005)
Carisoprodol intoxications and serotonergic features
Clin Toxicol (Phila), 43 (1), 39-45
DOI 10.1081/clt-45020, PubMed 15732445

Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Mørland J (2005)
The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects
Eur J Clin Pharmacol, 61 (7), 499-506
DOI 10.1007/s00228-005-0970-1, PubMed 16021435

Bramness JG, Skurtveit S, Mørland J (2005)
Flunitrazepam: psychomotor impairment, agitation and paradoxical reactions
Forensic Sci Int, 159 (2-3), 83-91
DOI 10.1016/j.forsciint.2005.06.009, PubMed 16087304

Gustavsen I, Mørland J, Bramness JG (2005)
Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers
Accid Anal Prev, 38 (3), 490-5
DOI 10.1016/j.aap.2005.11.005, PubMed 16343411

Olsen V, Gustavsen I, Bramness JG, Hasvold I, Karinen R, Christophersen AS, Mørland J (2005)
The concentrations, appearance and taste of nine sedating drugs dissolved in four different beverages
Forensic Sci Int, 151 (2-3), 171-5
DOI 10.1016/j.forsciint.2005.01.017, PubMed 15939149

Publications 2004

Bramness JG, Skurtveit S, Mørland J (2004)
Impairment due to intake of carisoprodol
Drug Alcohol Depend, 74 (3), 311-8
DOI 10.1016/j.drugalcdep.2004.01.007, PubMed 15194209

Publications 2003

Bramness JG, Skurtveit S, Fauske L, Grung M, Molven A, Mørland J, Steen VM (2003)
Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
Pharmacogenetics, 13 (7), 383-8
DOI 10.1097/01.fpc.0000054098.48725.88, PubMed 12835613

Bramness JG, Skurtveit S, Mørland J (2003)
Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers
Eur J Clin Pharmacol, 59 (8-9), 593-601
DOI 10.1007/s00228-003-0677-0, PubMed 14504853

Publications 2002

Bramness J, Aasland OG (2002)
[Substance abuse and neurobiology]
Tidsskr Nor Laegeforen, 122 (23), 2311-2
PubMed 12448278

Bramness JG, Bachs LC, Waal H (2002)
[Buprenorphine as maintenance treatment in rehabilitation of heroin addicts]
Tidsskr Nor Laegeforen, 122 (25), 2452-4
PubMed 12448114

Bramness JG, Skurtveit S, Mørland J (2002)
Clinical impairment of benzodiazepines--relation between benzodiazepine concentrations and impairment in apprehended drivers
Drug Alcohol Depend, 68 (2), 131-41
DOI 10.1016/s0376-8716(02)00188-6, PubMed 12234642

Publications 2001

Bachs LC, Bramness JG, Waal H (2001)
Buprenorfin i legemiddelassistert rehabilitering: hva vet vi i dag?
Statens rettstoksikologiske institutt, Oslo, [42] s.
BIBSYS 012276391, ISBN 82-91049-33-5

Bramness JG (2001)
[Lou Andreas-Salome (1861-1937)--psychoanalytical and feministic contribution to understanding her biography]
Tidsskr Nor Laegeforen, 121 (17), 2032-6
PubMed 11875901

Bramness JG, Arnestad M, Karinen R, Hilberg T (2001)
Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma
J Forensic Sci, 46 (5), 1247-9
PubMed 11569575

Publications 2000

Bachs LC, Bramness JG, Waal H (2000)
Buprenorfin: en litteraturgjennomgang
MARIO, Oslo, [23] bl.
BIBSYS 001486209

Bramness JG, Skurtveit S, Grung M, Mørland J (2000)
[Centrally acting muscle relaxants and traffic hazards]
Tidsskr Nor Laegeforen, 120 (17), 1966-9
PubMed 11008526

Publications 1999

Bramness JG (1999)
[The bell tolls for Ernest Hemingway. Somatic, psychiatric and psychoanalytical aspects of his life and work]
Tidsskr Nor Laegeforen, 119 (17), 2477-81
PubMed 10425900

Bramness JG, Skurtveit S, Mørland J (1999)
[Detection of zopiclone in many drivers--a sign of misuse or abuse]
Tidsskr Nor Laegeforen, 119 (19), 2820-1
PubMed 10494203

Publications 1998

Bramness JG, Olsen H (1998)
[Adverse effects of zopiclone]
Tidsskr Nor Laegeforen, 118 (13), 2029-32
PubMed 9656789

Publications 1996

Bramness JG (1996)
[Interruptions of physicians' work at hospitals]
Tidsskr Nor Laegeforen, 116 (14), 1719
PubMed 8658445

Bramness JG (1996)
[Save us from idiocy]
Tidsskr Nor Laegeforen, 116 (17), 2083
PubMed 8779151

Publications 1992

Bramness J (1992)
[Why change medical education? The reason for changing medical education]
Tidsskr Nor Laegeforen, 112 (2), 234-5
PubMed 1566263

Bramness JG (1992)
[Admission criteria for medical studies]
Tidsskr Nor Laegeforen, 112 (18), 2390
PubMed 1412249

Bramness JG, Fixdal TC, Vaglum P (1992)
[Socialization of physician's role during the clinical part of medical education. 1: Students' assessment of own skills]
Tidsskr Nor Laegeforen, 112 (17), 2207-10
PubMed 1523659

Bramness JG, Vaglum P (1992)
[Socialization of physician's role during the clinical part of medical education. 2: Students' identification with physician's role]
Tidsskr Nor Laegeforen, 112 (17), 2211-3
PubMed 1523660

Publications 1991

Bramness JG, Fixdal TC, Vaglum P (1991)
Effect of medical school stress on the mental health of medical students in early and late clinical curriculum
Acta Psychiatr Scand, 84 (4), 340-5
DOI 10.1111/j.1600-0447.1991.tb03157.x, PubMed 1746285